Hester Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Hester Biosciences Ltd · Outcome · 05 Nov 2026, 4:42 pm
Hester Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) â– Revenue: 979 (+38.0% YoY | +26.8% QoQ) â– EBITDA: 327 (+178.7% YoY | +43.4% QoQ) â– EBITDA Margin (%): 33.4 (+1685 bps YoY | +387 bps QoQ) â– PAT: 204 (+40.9% YoY | -79.0% QoQ) â– EPS (INR): 23.9 (+42.1% YoY | -79.0% QoQ) Hester Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Poultry Healthcare â– Revenue: 623 (+29.7% YoY | +0.2% QoQ) â– EBIT: 207 (+52.9% YoY | -15.0% QoQ) â– EBIT Margin (%): 33.2 (+504 bps YoY | -592 bps QoQ) Animal Healthcare â– Revenue: 356 (+55.3% YoY | +135.9% QoQ) â– EBIT: 96.3 (+181.4% YoY | Loss to Profit QoQ) â– EBIT Margin (%): 27.0 (+1211 bps YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Hester Biosciences Ltd
- 20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results · 07 Nov 2026
- Audio recording of the Earnings Conference Call for Q2 FY 27 · 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange about Board have approved an Unsecured loan of an aggregate amount of USD 1 million to Hester Biosciences Africa Limited( Hester Africa ), foreign wholly-owned subsidiary in Tanzania, in one or more tranches. · 05 Nov 2026
- Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited, Foreign wholly-owned subsidiary of the Company. · 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "20261105 Q2 & H1 FY27 Press Release". · 05 Nov 2026
- 20261105 Q2 & H1 FY27 Press Release · 05 Nov 2026
- Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor .... · 05 Nov 2026
